Pharmaceutical

Allink Biotherapeutics secures funding to advance ADC pipeline

Allink Biotherapeutics has completed a $42m Series A financing round to expedite the worldwide development of its ADC pipeline.

Nov 29, 2024 - 06:00
Allink Biotherapeutics secures funding to advance ADC pipeline
Allink Biotherapeutics has completed a $42m Series A financing round to expedite the worldwide development of its ADC pipeline.
Read the original article

Tags:

Previous Article

Sustainability in biopharma: Collaboration and technology light the way forward

Next Article

Formosa and Medvisis agree on post-operative eye pain therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

How competitive intelligence can give pharma companies an edge

How competitive intelligence can give pharma companies ...

Aug 18, 2023

White House delays menthol cigarette ban, alarming anti-smoking advocates

White House delays menthol cigarette ban, alarming anti...

Dec 7, 2023

Alvotech and Bioventure gain approval for Humira biosimilar in Egypt

Alvotech and Bioventure gain approval for Humira biosim...

Aug 30, 2023